We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.08%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$644M
AUM Growth
+$39.6M
(+6.6%)
Cap. Flow
+$5.56M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
35.41%
Holding
200
New
77
Increased
40
Reduced
23
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$12.7M |
| 3 |
CELG
Celgene Corp
CELG
|
+$12.4M |
| 4 |
PEGI
Pattern Energy Group Inc. Class A
PEGI
|
+$8.27M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$7.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$15M |
| 2 |
AKRX
Akorn Inc
AKRX
|
+$12.7M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$9.32M |
| 4 |
GLBL
TerraForm Global, Inc. Class A Common Stock
GLBL
|
+$7.95M |
| 5 |
MRT
MedEquities Realty Trust, Inc.
MRT
|
+$7.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.08% |
| 2 | Technology | 10.1% |
| 3 | Financials | 8.58% |
| 4 | Energy | 7.12% |
| 5 | Real Estate | 6.18% |
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
FWM
Ardsley Advisory Partners's Q1 2017 Portfolio in Review
As of Q1 2017, Ardsley Advisory Partners held 200 positions worth $644M, up 6.6% from $604M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ardsley Advisory Partners's Q1 2017 filing shows 77 new, 40 increased, 23 reduced and 50 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 89,500 shares worth $7.86M. The largest sale was NorthStar Realty Finance Corp., an estimated $15M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.
- Ardsley Advisory Partners's largest Q1 2017 buy was BioMarin Pharmaceuticals: 89,500 shares worth $7.86M.
- Ardsley Advisory Partners added most to State Street SPDR S&P Biotech ETF in Q1 2017, an estimated $14.2M increase.
- Ardsley Advisory Partners's biggest Q1 2017 reduction was Akorn Inc, cutting an estimated $12.7M.
- Ardsley Advisory Partners fully exited NorthStar Realty Finance Corp. in Q1 2017, selling an estimated $15M.
- Ardsley Advisory Partners's ten largest holdings make up 35% of its $644M portfolio in Q1 2017.
- Ardsley Advisory Partners opened 77 new positions and closed 50 in Q1 2017.
- Ardsley Advisory Partners's portfolio value rose 6.6% quarter-over-quarter to $644M.
Based on Ardsley Advisory Partners's 13F filing for Q1 2017, filed 15 May 2017.